Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms

International Immunopharmacology
J BayryS Kaveri

Abstract

Intravenous immunoglobulin (IGIV) has increasingly been used for the treatment of autoimmune and systemic inflammatory diseases in addition to supportive therapy of immunodeficient patients. IGIV is beneficial in several diseases, including acute and chronic/relapsing diseases, autoimmune diseases and inflammatory disorders. Therapeutic efficacy of IGIV has also been established in a number of dermatologic diseases. Although a considerable progress has been made in understanding the mechanisms by which IGIV exerts immunomodulatory functions in autoimmune diseases, they remain not fully elucidated. The mode of action of IGIV is complex, involving modulation of expression and function of Fc receptors, interference with activation of complement and the cytokine network, modulation of idiotype network, regulation of cell growth, alteration of cellular adhesion process, and effects on the activation differentiation and effector functions of T and B cells and of antigen-presenting cells. The therapeutic effects of IGIV most likely reflect the functions of natural antibodies in maintaining immune homeostasis in healthy people. The ability of IGIV to interact through V regions with complementary V regions of antibodies and antigen rece...Continue Reading

References

Sep 1, 1992·Journal of Clinical Immunology·I N van SchaikA Brand
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J J MarchalonisA B Edmundson
Jun 1, 1994·Immunological Reviews·U AnderssonJ Andersson
Jan 1, 1996·Clinical Pediatrics·M E RyanJ D Statler
Apr 1, 1997·Clinical Immunology and Immunopathology·J F ModianoE W Gelfand
May 1, 1997·Annals of Internal Medicine·M C Dalakas
Aug 1, 1997·The Journal of Allergy and Clinical Immunology·M Ballow
Oct 23, 1997·Clinical Neuropharmacology·M StangelR Gold
Jun 5, 1998·Immunology Today·K BendtzenM Svenson
Sep 22, 1998·Scandinavian Journal of Immunology·T E MollnesR Perricone
Jan 23, 1999·The New England Journal of Medicine·Z Yu, V A Lennon
Jul 24, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·K C BholA R Ahmed
Sep 8, 2001·The New England Journal of Medicine·M D Kazatchkine, S V Kaveri
Dec 4, 2002·Immunology·W A C Sewell, S Jolles
Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Frank AltznauerHans-Uwe Simon
Feb 6, 2004·Journal of the European Academy of Dermatology and Venereology : JEADV·N SamiA R Ahmed
May 20, 2004·JAMA : the Journal of the American Medical Association·Marinos C Dalakas
May 29, 2004·Trends in Pharmacological Sciences·Jagadeesh BayrySrini V Kaveri
Jul 13, 2004·Science·Ralph M Steinman, Ira Mellman
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jagadeesh BayrySrini V Kaveri

❮ Previous
Next ❯

Citations

Apr 20, 2011·Current Rheumatology Reports·Adam Quick, Rup Tandan
May 20, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Andrew C IssekutzFabian Käsermann
Jan 31, 2012·Medicina clínica·Rocío Ramos-MedinaSilvia Sánchez-Ramón
Aug 27, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Andrew C IssekutzDerek Rowter
Jul 21, 2009·La Revue de médecine interne·M Gousseff, Z Amoura
Apr 28, 2009·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Toshiyuki KoyaFumitake Gejyo
Mar 3, 2009·Journal of the American Academy of Dermatology·Jeanmarie B Rey, Rebecca B Luria
Sep 25, 2007·Journal of Autoimmunity·Stratis AvrameasPeggy Lymberi
Jan 21, 2010·Acta Neurologica Scandinavica·I Elovaara, A Hietaharju
Apr 16, 2014·Pediatrics International : Official Journal of the Japan Pediatric Society·UNKNOWN Research Committee of the Japanese Society of Pediatric Cardiology, UNKNOWN Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease
Dec 14, 2007·Expert Opinion on Therapeutic Targets·Thiruma V ArumugamMark P Mattson
Feb 6, 2007·International Immunopharmacology·Elisabeth MaierHans Peter Schwarz
Mar 23, 2018·Expert Review of Cardiovascular Therapy·Noor Ul-Ain BalochOmar Rahman
Oct 24, 2012·Journal of Korean Medical Science·Se Jin ParkJae Il Shin
Jun 17, 2008·Critical Care Medicine·Marc LambertPierre-Yves Hatron
Aug 26, 2006·Pediatric Blood & Cancer·Andrew R CrowAlan H Lazarus
Nov 1, 2007·Dermatologic Therapy·Anthony P Fernandez, Francisco A Kerdel
Aug 28, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sven G MeuthHeinz Wiendl
Apr 11, 2007·Current Opinion in Nephrology and Hypertension·Patrick D Walker
Mar 31, 2012·Nature Reviews. Drug Discovery·P Mark Hogarth, Geoffrey A Pietersz
May 23, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Thomas ThieleAndreas Greinacher
Feb 5, 2014·Expert Review of Clinical Immunology·Alessandro M MarraEdoardo Rosato
Jun 15, 2010·Reproductive Medicine and Biology·Shigeki ShimadaHisanori Minakami
Feb 9, 2011·Clinical Neuropharmacology·Irina ElovaaraBirgit Reipert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis